Evaluation of new treatments in radiation oncology: are they better than standard treatments?
about
New treatments compared to established treatments in randomized trialsNew treatments compared to established treatments in randomized trialsAre experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology GroupPancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancerFound in translation: Integrating laboratory and clinical oncology researchSystematic review of the empirical evidence of study publication bias and outcome reporting biasOptimism bias leads to inconclusive results-an empirical study.Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty.Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.Small animal image-guided radiotherapy: status, considerations and potential for translational impact.Treatment success in pragmatic randomised controlled trials: a review of trials funded by the UK Health Technology Assessment programme.Description of the protocols for randomized controlled trials on cancer drugs conducted in Spain (1999-2003).The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.The paradox of equipoise: the principle that drives and limits therapeutic discoveries in clinical research.Lessons learned from radiation oncology clinical trials.Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges.Accrual to Trans-Tasman Radiation Oncology Group-sponsored trials 2010-2012.When Null Hypothesis Significance Testing Is Unsuitable for Research: A Reassessment.Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.Ancillary care in public health intervention research in low-resource settings: researchers' practices and decision-making.Radiological protection in ion beam radiotherapy: practical guidance for clinical use of new technology.Health technology assessment: an evidence-based medicine perspective.Accident prevention in day-to-day clinical radiation therapy practice.Phase I trials involving radiation therapy, quantifying the risks.Better to be in The Placebo Arm for Trials of Neurological Therapies?Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
P2860
Q24198868-BD5DB576-413B-4F12-BDF4-57222EEE2F3EQ24246150-1F7E49D8-3AFF-405C-B168-9DA57C969080Q24536914-66515A90-9F59-4C91-9A83-01FCB7527F25Q24631880-D8BB9FF6-A4FB-4041-B00C-3327ED552540Q28744471-EA8A7170-2A22-40AB-8373-4A3A63F7C56DQ29619094-5C8F388E-1F38-47BF-8D62-12668A157042Q30426685-E2BF8E6B-55A3-483E-8467-622D9133DF1DQ33851241-E9612A10-690C-461B-AB66-A93B255AC67FQ34650505-23588B7A-5499-45AB-9413-0043F82D8BB0Q34776573-D616EEFE-2BCA-4DE4-843B-C88AF9E86512Q35042324-ECB3D147-0B99-4CCD-8892-0DD871D6DBA4Q35043881-5280570B-53AB-44D1-82EE-32590D1614FCQ37095602-7FCD0C29-6F81-454E-8750-7C26DBD3A882Q37295343-F330A325-2968-4600-A10F-1FCC7D3667F5Q37412411-AC0E63E4-2F98-48E9-A3E6-B9F8F8358620Q37436702-1FF56F66-E9D1-4F62-B88B-0EE72523B91BQ37662359-0779ECC6-9DDE-42D8-B262-76B33450F903Q37993783-233C4F34-1D01-497F-BDA1-263CFD5D88E2Q38122788-E6538D9D-51B9-47B9-AB62-EE449F1AABCAQ38616823-58653D99-5F33-4E6B-A093-2DAA4461F6C5Q40158198-3C506B21-589A-4AE1-AAC2-7F01A62BEC6EQ44757834-04B309A4-6050-40D2-A4DE-7C14C57F39E7Q48847893-9E40FAC8-7825-464B-947A-4ADA88D1E94CQ53111768-358B079E-0118-4FC4-BED8-E224A32B026DQ53121879-E25E01FC-3F59-4EA2-8EA0-306E498CEBAAQ54526137-3E8A8897-C1D3-4440-A5F6-40FB33DA0582Q55642155-2DEC59B4-A5B2-456A-B63C-AA3C003C767AQ57542870-5324358B-7416-4CF9-9400-B7AFCB3E36BE
P2860
Evaluation of new treatments in radiation oncology: are they better than standard treatments?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evaluation of new treatments i ...... tter than standard treatments?
@ast
Evaluation of new treatments i ...... tter than standard treatments?
@en
type
label
Evaluation of new treatments i ...... tter than standard treatments?
@ast
Evaluation of new treatments i ...... tter than standard treatments?
@en
prefLabel
Evaluation of new treatments i ...... tter than standard treatments?
@ast
Evaluation of new treatments i ...... tter than standard treatments?
@en
P2093
P2860
P356
P1476
Evaluation of new treatments i ...... tter than standard treatments?
@en
P2093
Alan Cantor
Ambuj Kumar
Andy Trotti
Clement Gwede
Fadila Serdarevic
Heloisa P Soares
Mike Clark
Stephanie Daniels
Suzanne Swann
P2860
P304
P356
10.1001/JAMA.293.8.970
P407
P577
2005-02-01T00:00:00Z